4.1 Article

Genetic differentiation of populations residing in areas of high malaria endemicity in India

期刊

JOURNAL OF GENETICS
卷 88, 期 1, 页码 77-80

出版社

INDIAN ACAD SCIENCES
DOI: 10.1007/s12041-009-0010-5

关键词

falciparium malaria; single nucleotide polymorphism (SNP); tumour necrosis factor; human genetics; Indian populations

资金

  1. Council for Scientific and Industrial Research (CMM0016)
  2. Government of India [BT/PR6065/MED/14/738/2005]

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Physiology

Short palate, lung, and nasal epithelial clone 1 (SPLUNC1) level determines steroid-resistant airway inflammation in aging

Anil Kumar Jaiswal, Jyoti Yadav, Sangeet Makhija, Maninder Sandey, Amol Suryawanshi, Amit Kumar Mitra, Amarjit Mishra

Summary: The study found that aged mice exhibit increased airway hyperresponsiveness, mixed granulomatous airway inflammation, and changes in immune response, suggesting that the development of airway inflammation may be age-related. Additionally, the age-dependent decline in SPLUNC1 levels may be involved in developing steroid-resistant airway inflammation and asthma heterogeneity.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2022)

Article Oncology

Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer

Chameera Ekanayake Weeramange, Danhua Shu, Kai Dun Tang, Jyotsna Batra, Rahul Ladwa, Lizbeth Kenny, Sarju Vasani, Ian H. Frazer, Riccardo Dolcetti, Jonathan J. Ellis, Richard A. Sturm, Paul Leo, Chamindie Punyadeera

Summary: The risk of human papillomavirus (HPV)-positive head and neck cancer (HNC) is associated with distinct human leukocyte antigen (HLA) variants, some of which are shared by both cervical cancer and HPV-positive HNC. Several previous genome-wide association studies were replicated in this study, but the associations were limited to the HPV-positive HNC group.

CANCER (2022)

Article Oncology

Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation

Abdelrahman H. Elsayed, Xueyuan Cao, Amit K. Mitra, Huiyun Wu, Susana Raimondi, Christopher Cogle, Zeina Al-Mansour, Raul C. Ribeiro, Alan Gamis, Edward Anders Kolb, Richard Aplenc, Todd A. Alonzo, Soheil Meshinchi, Jeffrey Rubnitz, Stanley Pounds, Jatinder K. Lamba

Summary: A patient-specific polygenic score was established to personalize acute myeloid leukemia (AML) treatment. Patients with low ACS10 score had significantly worse outcomes with standard therapy, but showed improvement with augmented therapy. The polygenic ACS10 score can identify patients with unfavorable pharmacogenetic characteristics and offer potential for elective augmented therapy.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Immunology

Irg1/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation

Anil Kumar Jaiswal, Jyoti Yadav, Sangeet Makhija, Suman Mazumder, Amit Kumar Mitra, Amol Suryawanshi, Maninder Sandey, Amarjit Mishra

Summary: The study revealed a direct regulatory role of the Irg1/itaconate pathway in dendritic cells for the development of airway inflammation, suggesting a possible therapeutic target in modulating allergic asthma.

MUCOSAL IMMUNOLOGY (2022)

Article Biochemical Research Methods

Prediction of transcript structure and concentration using RNA-Seq data

Harsh Sharma, Trishna Pani, Ujjaini Dasgupta, Jyotsna Batra, Ravi Datta Sharma

Summary: Alternative splicing (AS) is a key post-transcriptional modification that increases protein diversity. Many protein-coding genes in humans undergo AS and code for different transcripts, some of which are associated with diseases. A pipeline called FASE has been developed to determine the structure and concentration of transcripts, and it can efficiently predict novel transcripts for the identification of biomarkers and therapeutics.

BRIEFINGS IN BIOINFORMATICS (2023)

Review Biochemistry & Molecular Biology

The roles of proteases in prostate cancer

Hannu Koistinen, Ruusu-Maaria Kovanen, Morley D. Hollenberg, Antoine Dufour, Evette S. Radisky, Ulf-Hakan Stenman, Jyotsna Batra, Judith Clements, John D. Hooper, Eleftherios Diamandis, Oliver Schilling, Antti Rannikko, Tuomas Mirtti

Summary: Since the proposition of the pro-invasive activity of proteolytic enzymes over 70 years ago, several roles for proteases in cancer progression have been established. About half of the 473 active human proteases are expressed in the prostate and many of the most well-characterized members of this enzyme family are regulated by androgens, hormones essential for development of prostate cancer. Most notably, several kallikrein-related peptidases, including KLK3 (prostate-specific antigen, PSA), the most well-known prostate cancer marker, and type II transmembrane serine proteases, such as TMPRSS2 and matriptase, have been extensively studied and found to promote prostate cancer progression. Recent findings also suggest a critical role for proteases in the development of advanced and aggressive castration-resistant prostate cancer (CRPC). Perhaps the most intriguing evidence for this role comes from studies showing that the protease-activated transmembrane proteins, Notch and CDCP1, are associated with the development of CRPC.

IUBMB LIFE (2023)

Article Orthopedics

Dysregulated energy metabolism impairs chondrocyte function in osteoarthritis

X. Wu, C. Liyanage, M. Plan, T. Stark, T. McCubbin, R. A. Barrero, J. Batra, R. Crawford, Y. Xiao, I. Prasadam

Summary: This study aims to identify the changes in energy metabolism in osteoarthritis (OA) cartilage. Metabolomics, proteomics, and transcriptomics analyses were conducted to investigate the global alterations in OA metabolism. The results showed increased lactate production and decreased mitochondrial respiratory rates in OA chondrocytes. This study provides a basis for targeting metabolism as a therapeutic approach for OA.

OSTEOARTHRITIS AND CARTILAGE (2023)

Article Genetics & Heredity

Severe COVID-19 May Impact Hepatic Fibrosis/Hepatic Stellate Cells Activation as Indicated by a Pathway and Population Genetic Study

Leire Moya, Samaneh Farashi, Prashanth Suravajhala, Panchadsaram Janaththani, Jyotsna Batra

Summary: COVID-19 has caused significant impacts globally, infecting over 112 million people and causing more than 2.5 million deaths. In Europe, Spain and Italy had a high number of COVID-19 related deaths, while many infected individuals did not develop severe illness. Researchers speculated that unique genomic characteristics in these populations could contribute to a poorer prognosis.
Article Oncology

Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer

Suman Mazumder, Taraswi Mitra Ghosh, Ujjal K. Mukherjee, Sayak Chakravarti, Farshad Amiri, Razan S. Waliagha, Farnaz Hemmati, Panagiotis Mistriotis, Salsabil Ahmed, Isra Elhussin, Ahmad-Bin Salam, Windy Dean-Colomb, Clayton Yates, Robert D. Arnold, Amit K. Mitra

Summary: Prostate cancer (PCa) is a major cause of cancer deaths in US men. Drug resistance and specific cancer subtypes, such as epithelial-to-mesenchymal transdifferentiation (EMT) and neuroendocrine PCa (NEPC), pose significant challenges in PCa treatment. In this study, a computational prediction algorithm called secDrug identified potential secondary drugs for advanced-stage PCa. The proof-of-concept drug FK866, which targets NAMPT, showed promise in inhibiting drug resistance and stemness in PCa. The study also demonstrated the effects of FK866 on tumor metastasis, cell migration, and invasion, as well as regulation of genes associated with cancer stemness. The development pipeline introduced in this study has the potential to improve the management of lethal PCa.

CANCERS (2022)

Article Biochemistry & Molecular Biology

Network-based identification and prioritization of key transcriptional factors of diabetic kidney disease

Ikhlak Ahmed, Mubarak Ziab, Sahar Da'as, Waseem Hasan, Sujitha P. Jeya, Elbay Aliyev, Sabah Nisar, Ajaz A. Bhat, Khalid Adnan Fakhro, Ammira S. Alshabeeb Akil

Summary: Diabetic nephropathy (DN) is a common microvascular complication of diabetes that leads to end-stage renal disease. This study aimed to identify key transcription factors (TFs) associated with DN progression by performing a meta-analysis on gene expression profiles from multiple datasets. The analysis revealed distinct clusters of dysregulated susceptibility genes in different renal compartments, with a subset of these genes encoding critical TFs involved in DN development and podocyte function. The role of these TFs was validated in a hyperglycemic zebrafish model, showing that altered expression of these genes leads to morphological abnormalities in various kidney structures. This study provides insights into the molecular drivers, essential genes, and pathways involved in DN initiation and development.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2023)

Article Oncology

Characterisation of cell lines derived from prostate cancer patients with localised disease

Leire Moya, Carina Walpole, Fiona Rae, Srilakshmi Srinivasan, Inge Seim, John Lai, David Nicol, Elizabeth D. Williams, Judith A. Clements, Jyotsna Batra

Summary: This study successfully established four cell lines derived from localized prostate cancer, including two benign and two malignant cell lines. The characteristics and molecular events of these cell lines could help in understanding the development and progression of cancer.

PROSTATE CANCER AND PROSTATIC DISEASES (2023)

Article Multidisciplinary Sciences

Integrative competing endogenous RNA network analyses identify novel lncRNA and genes implicated in metastatic breast cancer

Dulari K. Jayarathna, Miguel E. Renteria, Jyotsna Batra, Neha S. Gandhi

Summary: This study identified stage-specific competing endogenous RNAs (ceRNAs) in breast cancer using cancer genome atlas data and investigated their molecular functions and prognostic ability. Five genes and one long non-coding RNA were found to be unique to the stage IV ceRNA network, and these genes have been described in previous breast cancer studies. Survival analysis identified prognostic microRNAs in stages I, II, and III. These findings reveal a set of unique ceRNAs in metastatic breast cancer, and further experimental work is needed to evaluate their role in metastasis. Identifying stage-specific ceRNAs will also contribute to the understanding of personalized therapeutics in breast cancer.

SCIENTIFIC REPORTS (2023)

Review Oncology

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer

Fatemeh Davoudi, Afshin Moradi, Therese M. M. Becker, John G. G. Lock, Brian Abbey, Davide Fontanarosa, Annette Haworth, Judith Clements, Rupert C. C. Ecker, Jyotsna Batra

Summary: Prostate cancer is a commonly diagnosed malignant neoplasm and a leading cause of cancer-related death in men worldwide. Personalized therapeutic strategies for this disease remain limited, but emerging biomarkers based on individual patient profiles and computer-assisted diagnostics have the potential to guide precision medicine. This review discusses screening methods, genetic aberrations, and phenotypic biomarkers for advanced prostate cancer, exploring their clinical implications in diagnosis, prognosis, and treatment prediction. Prognostic and treatment predictive biomarker discovery can improve patient management and personalized treatment regimens.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

Dynamics and recognition of homeodomain containing protein-DNA complex of IRX4

Adil Malik, Dulari K. Jayarathna, Mark Fisher, Tabassum Khair Barbhuiya, Neha S. Gandhi, Jyotsna Batra

Summary: In this study, the researchers investigated the mechanism of IRX4 homeodomain-DNA recognition and the impact of somatic mutations on these interactions using sequence analysis, homology modeling, and molecular dynamics simulations. They also identified the gene expression and protein expression of IRX4 in various tissues and highlighted the importance of conserved residues in DNA binding and the role of somatic mutations in destabilizing the protein-DNA complex. Additionally, they predicted that the C-terminal sequence of the IRX4 homeodomain could act as a potential cell-penetrating peptide.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2023)

Review Oncology

Remodelling of the tumour microenvironment by the kallikrein-related peptidases

Srilakshmi Srinivasan, Thomas Kryza, Jyotsna Batra, Judith Clements

Summary: This review discusses the complex biology of kallikrein-related peptidases and their role in cancer and the tumor microenvironment. It also explores their involvement in tumor immune suppression and resistance to cancer therapy. Understanding the functions of these peptidases can provide insights into tumor development and help in developing new therapeutic strategies.

NATURE REVIEWS CANCER (2022)

暂无数据